United States
Germany
Japan
United Kingdom
China
GOLM1 mouse monoclonal antibody, clone OTI6C9 (formerly 6C9)
| Applications | IF, IHC, WB |
| Reactivities | Human, Monkey |
Products
GOLM1 (Myc-DDK-tagged)-Human golgi membrane protein 1 (GOLM1), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
GOLM1 mouse monoclonal antibody, clone OTI4B12 (formerly 4B12)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey |
GOLM1 mouse monoclonal antibody, clone OTI2D6 (formerly 2D6)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
GOLM1 (Myc-DDK-tagged)-Human golgi membrane protein 1 (GOLM1), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
GOLM1 mouse monoclonal antibody, clone OTI4B3 (formerly 4B3)
| Applications | IF, IHC, WB |
| Reactivities | Human, Monkey |
GOLM1 mouse monoclonal antibody, clone OTI5F4 (formerly 5F4)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
GOLM1 mouse monoclonal antibody, clone OTI2F3 (formerly 2F3)
| Applications | IF, IHC, WB |
| Reactivities | Human |
GOLM1 mouse monoclonal antibody, clone OTI3D7 (formerly 3D7)
| Applications | IHC, WB |
| Reactivities | Human |
Recombinant protein of human golgi membrane protein 1 (GOLM1), transcript variant 1, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
GOLM1 mouse monoclonal antibody, clone OTI2D6 (formerly 2D6)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
GOLM1 mouse monoclonal antibody, clone OTI4B12 (formerly 4B12)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey |
GOLM1 mouse monoclonal antibody, clone OTI6C9 (formerly 6C9)
| Applications | IF, IHC, WB |
| Reactivities | Human, Monkey |
GOLM1 mouse monoclonal antibody, clone OTI4B3 (formerly 4B3)
| Applications | IF, IHC, WB |
| Reactivities | Human, Monkey |
GOLM1 (tGFP-tagged) - Human golgi membrane protein 1 (GOLM1), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
